J. Gómez-Vidal

发表

Synthesis of tetrahydrobenzoxazepine acetals with electron-withdrawing groups on the nitrogen atom. Novel scaffolds endowed with anticancer activity against breast cancer cells

J. Marchal, A. Aránega, J. Campos, 2004 .

Synthesis and anticancer activity studies of novel 1-(2,3-dihydro-5H-1,4 -benzodioxepin -3 -yl )uracil and (6'-substituted)-7-or 9 -(2,3 -dihydro -5H-1,4 -benzodioxepin -3 -yl ) -7H-or 9H-purines

J. Marchal, A. Aránega, J. Campos, 2006 .

Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias

E. Salido, J. A. Gómez-Vidal, M. Díaz-Gavilán, 2021, Journal of personalized medicine.

Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells

J. Correa-Basurto, M. Bello, N. de Pedro, 2021, Pharmaceuticals.

Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells

M. Rosales-Hernández, J. Correa-Basurto, Y. Sixto-López, 2021, Cellular and Molecular Neurobiology.

New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production.

E. Salido, A. Pey, M. Díaz-Gavilán, 2022, European journal of medicinal chemistry.

Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.

E. Salido, J. A. Gómez-Vidal, M. Díaz-Gavilán, 2018, Journal of medicinal chemistry.

Production of the Phanerochaete flavido-alba laccase in Aspergillus niger for synthetic dyes decolorization and biotransformation

Jose C. Martínez, E. Record, J. A. Gómez-Vidal, 2014, World journal of microbiology & biotechnology.

Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations

M. Rosales-Hernández, J. Correa-Basurto, Y. Sixto-López, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology.

Exploring the Potential binding Sites of Some Known HDAC Inhibitors on Some HDAC8 Conformers by Docking Studies

J. Correa-Basurto, Y. Sixto-López, J. Gómez-Vidal, 2014, Applied Biochemistry and Biotechnology.

A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells

H. Boulaiz, J. Marchal, A. Aránega, 2007, Breast Cancer Research and Treatment.

A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis

N. de Pedro, E. Belmonte-Reche, M. Díaz-Gavilán, 2019, Pharmacological research.

Effectiveness of an O-Alkyl Hydroxamate in Dogs with Naturally Acquired Canine Leishmaniosis: An Exploratory Clinical Trial

M. Díaz-Gavilán, J. Martín‐Sánchez, J. López-Viota, 2022, Animals : an open access journal from MDPI.

O-alkyl hydroxamates display potent and selective antileishmanial activity.

J. Correa-Basurto, N. de Pedro, Y. Sixto-López, 2020, Journal of medicinal chemistry.

Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations

M. Rosales-Hernández, J. Correa-Basurto, M. Bello, 2017, Journal of biomolecular structure & dynamics.

CCB, a novel specific κ opioid agonist, which discriminates between opioid and σ1 recognition sites

L. Carboni, L. Pasquinucci, J. A. Gómez-Vidal, 1995 .

Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds.

J. Lacal, J. Campos, J. A. Gómez-Vidal, 2002, Bioorganic & medicinal chemistry.

Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines

M. Rosales-Hernández, J. Correa-Basurto, M. Bello, 2020, Scientific Reports.

Short, highly efficient syntheses of protected 3-azido- and 4-azidoproline and their precursors.

R. Silverman, J. A. Gómez-Vidal, J. Gómez-Vidal, 2001, Organic letters.

In silico design of HDAC6 inhibitors with neuroprotective effects

M. Rosales-Hernández, J. Correa-Basurto, M. Bello, 2021, Journal of biomolecular structure & dynamics.

Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines

M. Rosales-Hernández, J. Correa-Basurto, M. Bello, 2020, Scientific Reports.

Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase

T. Poulos, Huiying Li, R. Silverman, 2004, Nature Structural &Molecular Biology.

Conformationally restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors.

Haitao Ji, P. Martásek, R. Silverman, 2006, Journal of medicinal chemistry.

Study of the factors that control the ratio of the products between 5-fluorouracil, uracil, and tetrahydrobenzoxazepine O,O-acetals bearing electron-withdrawing groups on the nitrogen atom.

J. Campos, M. Díaz-Gavilán, M. Gallo, 2006, The Journal of organic chemistry.

Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.

J. Marchal, A. Aránega, J. Campos, 2008, Bioorganic & medicinal chemistry letters.

Mild and selective sodium azide mediated cleavage of p-nitrobenzoic esters.

R. Silverman, J. A. Gómez-Vidal, M. T. Forrester, 2001, Organic letters.

Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases.

T. Poulos, Huiying Li, J. Igarashi, 2005, Biochemistry.

Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.

P. Martásek, R. Silverman, L. Roman, 2004, Journal of medicinal chemistry.

Production of the Phanerochaete flavido-alba laccase in Aspergillus niger for synthetic dyes decolorization and biotransformation

E. Record, T. de la Rubia, J. A. Gómez-Vidal, 2013, World Journal of Microbiology and Biotechnology.